We are a clinical stage company developing novel disease modifying drugs for the treatment of both neurodegenerative diseases and cancer. We are building our portfolio by both inventing new chemical entities in house and licensing promising leads from third parties.
Learn more about the team behind CMD and our unique philosophy and methods.
Find out about our organization, our mission, our methods, and our clinical trials.
CMD is a portfolio company of Cthulhu Ventures LLC